Advocacy intelligence hub — real-time data for patient organizations
Shehzad Basaria, M.D. — PHASE2
Children's Oncology Group — PHASE2, PHASE3
Apollo Therapeutics Ltd — PHASE1
McGill University Health Centre/Research Institute of the McGill University Health Centre — NA
AB Science — PHASE1, PHASE2
Maastricht University Medical Center
Novartis Pharmaceuticals — PHASE3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Nirmish Shah, MD
Duke University
📍 DURHAM, NC
Jorge Cortes, MD
UT MD Anderson Cancer Center
Manuel Häckl, MD
Basilea Pharmaceutica International Ltd, Allschwil
Ervin Epstein, MD, M.D
UCSF Benioff Children's Hospital Oakland
📍 OAKLAND, CA
Mitchell S Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY
Wyndham H Wilson, M.D., MD, PhD
National Cancer Institute (NCI)
📍 BETHESDA, MD